Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer

Published:2017-12 Issue: Volume:410 Page:169-179
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Hoang Bryan,Ernsting Mark J.,Tang Wei-Hsin Sophia,Bteich Joseph,Undzys Elijus,Kiyota Taira,Li Shyh-Dar^ORCID

Funder

Ontario Institute for Cancer Research Intellectual Property Development and Commercialization Fund

National Institutes of Health

Canadian Institutes of Health Research (CIHR)

proof-of-principal

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference56 articles.

1. Prostate cancer statistics: anything you want them to Be;Gomella;Can. J. Urol.,2017

2. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016

3. Overcoming drug resistance and treating advanced prostate cancer;Semenas;Curr. Drug Targets,2012

4. Mechanisms of bone metastasis in prostate cancer: clinical implications;Msaouel;Best. Pract. Res. Clin. Endocrinol. Metab.,2008

5. Impact of skeletal complications on patients' quality of life, mobility, and functional independence;Costa;Support Care Cancer,2008

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone targeted nano-drug and nano-delivery;Bone Research;2024-09-04

2. Cabazitaxel‐Loaded Thermosensitive Hydrogel System for Suppressed Orthotopic Colorectal Cancer and Liver Metastasis;Advanced Science;2024-06-27

3. IL-23 inhibitor enhances the effects of PTEN DNA-loaded lipid nanoparticles for metastatic CRPC therapy;Frontiers in Pharmacology;2024-06-05

4. Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation;Cancer and Metastasis Reviews;2024-02-19

5. A novel cabazitaxel liposomes modified with ginsenoside Rk1 for cancer targeted therapy;Acupuncture and Herbal Medicine;2024-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3